Common use of Royalty Reduction Clause in Contracts

Royalty Reduction. The royalties due to ALNYLAM under Section 3.9 above may be reduced on a country-by-country basis in the Territory by the amount of royalties paid or payable with respect to Necessary Third Party IP; provided, however, that royalties due to ALNYLAM under Section 3.9 may not be reduced by more than [**] of the royalties otherwise due (and will not in any case be reduced below [**] of the amount of royalties that would otherwise be due, e.g. for Net Sales up to and including [**] the minimum effective royalty rate would be [**]. For purposes of illustration only, if annual Net Sales of a PROTIVA Development Product are [**] and royalties due to Third Parties in respect of the sale of such product total [**] of Net Sales (or [**]), royalties due to ALNYLAM may be reduced only by [**] which is determined as follows: maximum reduction is [**] of the royalty due on Net Sales of [**], calculated by [**].

Appears in 2 contracts

Samples: Cross License Agreement (Tekmira Pharmaceuticals Corp), Cross License Agreement (Alnylam Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

Royalty Reduction. The Any royalties due to ALNYLAM PROTIVA under Section 3.9 4.9 above may be reduced on a country-by-country basis in the Territory by the amount of royalties paid or payable with respect to Necessary Third Party IP; provided, however, that royalties due to ALNYLAM PROTIVA under Section 3.9 4.9 may not be reduced by more than [**] of the royalties otherwise due (and will not in any case be reduced below [**] of the amount of royalties that would otherwise be due, e.g. for Net Sales up to and including [**] the minimum effective royalty rate would be [**]). For purposes of illustration only, if annual Net Sales of a PROTIVA an ALNYLAM Development Product are [**] and royalties due to Third Parties in respect of the sale of such product total [**] of Net Sales (or [**]), royalties due to ALNYLAM PROTIVA may be reduced only by [**] ], which is determined as follows: maximum reduction is [**] one-third of the royalty due on Net Sales of [**], calculated by [**].

Appears in 2 contracts

Samples: Cross License Agreement (Tekmira Pharmaceuticals Corp), Cross License Agreement (Alnylam Pharmaceuticals, Inc.)

Royalty Reduction. The Any royalties due to ALNYLAM PROTIVA under Section 3.9 4.9 above may be reduced on a country-by-country basis in the Territory by the amount of royalties paid or payable with respect to Necessary Third Party IP; provided, however, that royalties due to ALNYLAM PROTIVA under Section 3.9 4.9 may not be reduced by more than [**] of the royalties otherwise due (and will not in any case be reduced below [**] of the amount of royalties that would otherwise be due, e.g. for Net Sales up to and including [**] the minimum effective royalty rate would be [**]). For purposes of illustration only, if annual Net Sales of a PROTIVA an ALNYLAM Development Product are [**] and royalties due to Third Parties in respect of the sale of such product total [**] of Net Sales (or [**]), royalties due to ALNYLAM PROTIVA may be reduced only by [**] ], which is determined as follows: maximum reduction is [**] one-third of the royalty due on Net Sales of [**], calculated by [**].

Appears in 1 contract

Samples: Cross License Agreement (TEKMIRA PHARMACEUTICALS Corp)

AutoNDA by SimpleDocs

Royalty Reduction. The royalties due to ALNYLAM under Section 3.9 above may be reduced on a country-by-country basis in the Territory by the amount of royalties paid or payable with respect to Necessary Third Party IP; provided, however, that royalties due to ALNYLAM under Section 3.9 may not be reduced by more than [**] of the royalties otherwise due (and will not in any case be reduced below [**] of the amount of royalties that would otherwise be due, e.g. for Net Sales up to and including [**] the minimum effective royalty rate would be [**]). For purposes of illustration only, if annual Net Sales of a PROTIVA Development Product are [**] and royalties due to Third Parties in respect of the sale of such product total [**] of Net Sales (or [**]), royalties due to ALNYLAM may be reduced only by [**] which is determined as follows: maximum reduction is [**] of the royalty due on Net Sales of [**], calculated by [**].

Appears in 1 contract

Samples: Cross License Agreement (TEKMIRA PHARMACEUTICALS Corp)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!